Repeated administration of centhaquin to pregnant rats did not affect postnatal development and expression of endothelin receptors in the brain, heart or kidney of pups

Arzneimittel-Forschung/Drug Research

Volumn 62, Issue 12, 2012, Pages 670-676

  Briyal, S ^a   Lavhale, M S ^b   Gulati, A ^a  

^a MIDWESTERN UNIVERSITY   (United States)

^b Pharmazz Research Center   (India)

Author keywords

centhaquin; central nervous system; endothelin; ET A receptors; ETB receptors; postnatal development

Indexed keywords

CENTHAQUIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; BRAIN; BRAIN WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GROUPS BY AGE; HEART; HEART WEIGHT; IMMUNOBLOTTING; KIDNEY; KIDNEY MASS; MALE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIHYPERTENSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; FEMALE; HEART; KIDNEY; MALE; MYOCARDIUM; PIPERAZINES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 84871832237     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0032-1329985     Document Type: Article

References (29)

1. Srimal R. C., Mason DF J., Dhawan B. N. Studies on 2-(2-(4-(3- methylphenyl)1-piperazinyl)ethyl quinoline (centhaquine), a centrally acting antihypertensive II. Effect of cardiohemodynamics. Asia Pac J Pharmacol: 1990; 5 185 190 (Pubitemid 20339903)
2. Gulati A., Hussain G., Srimal R. C. Effect of repeated administration of centhaquin, a centrally acting hypotensive drug, on adrenergic, cholinergic (muscarinic), dopaminergic, and serotonergic receptors in brain-regions of rat. Drug Develop Res: 1991; 23 307 323
3. Srimal R. C., Gulati K., Nityanand S. et al. Pharmacological studies on 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl) quinoline (centhaquin). I. Hypotensive activity. Pharmacol Res: 1990; 22 319 329 (Pubitemid 20377025)
4. Gulati A., Lavhale M. S., Garcia D. J. et al. Centhaquin improves resuscitative effect of hypertonic saline in hemorrhaged rats. J Surg Res: 2012; 178 415 423
5. Andurkar S. V., Gulati A. Assessment of the analgesic effect of centhaquin in mouse tail flick and hot-plate tests. Pharmacology: 2011; 88 233 241
6. Sharma A. C., Gulati A. Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med: 1995; 23 874 884
7. Timmermans P. B., Van Zwieten P. A. Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933. Eur J Pharmacol: 1980; 63 199 202 (Pubitemid 10105512)
8. Yoo K. H., Yim H. E., Jang G. Y. et al. Endothelin A receptor blockade influences apoptosis and cellular proliferation in the developing rat kidney. J Korean Med Sci: 2009; 24 138 145
9. Kurihara Y., Kurihara H., Suzuki H. et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature: 1994; 368 307 310
10. Kurihara Y., Kurihara H., Oda H. et al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest: 1995; 96 293 300
11. Brand M., Le Moullec J. M., Corvol P. et al. Ontogeny of endothelins-1 and -3, their receptors, and endothelin converting enzyme-1 in the early human embryo. J Clin Invest: 1998; 101 549 559 (Pubitemid 28084237)
12. Gulati A., Kumar A., Morrison S. et al. Effect of centrally administered endothelin agonists on systemic and regional blood circulation in the rat: role of sympathetic nervous system. Neuropeptides: 1997; 31 301 309 (Pubitemid 27394774)
13. Gulati A., Rebello S., Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am J Physiol: 1997; 273 1177 1186
14. Souza H. C., Terzini G. C., da Silva V. J. et al. Increased cardiac sympathetic drive and reduced vagal modulation following endothelin receptor antagonism in healthy conscious rats. Clin Exp Pharmacol Physiol: 2008; 35 751 756 (Pubitemid 351728054)
15. Gulati A. Evidence for antagonistic activity of endothelin for clonidine induced hypotension and bradycardia. Life Sci: 1992; 50 153 160
16. Gulati A., Srimal R. C. Endothelin antagonizes the hypotension and potentiates the hypertension induced by clonidine. Eur J Pharmacol: 1993; 230 293 300 (Pubitemid 23031212)
17. Lavhale M. S., Briyal S., Parikh N. et al. Endothelin modulates the cardiovascular effects of clonidine in the rat. Pharmacol Res: 2010; 62 489 499
18. DAngelo G., Pollock J. S., Pollock D. M. In vivo evidence for endothelin-1-mediated attenuation of alpha1-adrenergic stimulation. Am J Physiol Heart Circ Physiol: 2006; 290 1251 1258
19. Vazquez-Prado J., Medina L. C., Garcia-Sainz J. A. Activation of endothelin ETA receptors induces phosphorylation of alpha1b-adrenoreceptors in Rat-1 fibroblasts. J Biol Chem: 1997; 272 27330 27337 (Pubitemid 27452699)
20. Gulati A., Arora R. C., Crayton J. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin. Eur J Pharmacol: 1993; 231 151 156 (Pubitemid 23050894)
21. Briyal S., Philip T., Gulati A. Endothelin-A Receptor Antagonists Prevent Amyloid-beta-Induced Increase in ETA Receptor Expression, Oxidative Stress, and Cognitive Impairment. J Alzheimers Dis: 2011; 23 491 503
22. Leonard M. G., Briyal S., Gulati A. Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats. Brain Res: 2011; 1420 48 58
23. Lowry O. H., Rosebrough N. J., Farr A. L. et al. Protein measurement with the Folin phenol reagent. J Biol Chem: 1951; 193 267 275
24. Gulati A., Bhalla S., Matwyshyn G. et al. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874. Pharmacology: 2009; 83 45 58
25. Pla P., Larue L. Involvement of endothelin receptors in normal and pathological development of neural crest cells. Int J Dev Biol: 2003; 47 315 325 (Pubitemid 36975690)
26. Heanue T. A., Pachnis V. Enteric nervous system development and Hirschsprungs disease: advances in genetic and stem cell studies. Nat Rev Neurosci: 2007; 8 466 479 (Pubitemid 46789228)
27. Leonard M. G., Briyal S., Gulati A. Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats. Brain Res: 2012; 1464 14 23
28. Chuquet J., Benchenane K., Toutain J. et al. Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke: 2002; 33 3019 3025 (Pubitemid 35462881)
29. Quinn R. Comparing rats to humans age: how old is my rat in people years? Nutrition: 2005; 21 775 777 (Pubitemid 40733575)